Arbutus Biopharma Corpora... (ABUS)
NASDAQ: ABUS
· Real-Time Price · USD
3.33
-0.04 (-1.19%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.01%
After-hours: Aug 15, 2025, 05:47 PM EDT
Arbutus Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 37.41M | 37.08M | 36.33M | 31.85M | 62.79M | 43.1M | 26.29M | 17.53M | 27.2M | 40.57M | 30.78M | 24M | 47.32M | 81.33M | 109.28M | 77.88M | 30.95M | 79.42M |
Short-Term Investments | 60.68M | 75.63M | 86.29M | 95.95M | 79.2M | 86.14M | 99.72M | 116.65M | 125.29M | 106.15M | 116.14M | 110.71M | 102.88M | 84.15M | 46.03M | 43.52M | 47.42M | 52.54M |
Long-Term Investments | n/a | n/a | n/a | 2.96M | 6.53M | 8.68M | 6.28M | 10.5M | 11.06M | 31.79M | 37.36M | 55.44M | 50.45M | 56.32M | 35.69M | 30.53M | 42.91M | n/a |
Other Long-Term Assets | n/a | 34K | 34K | n/a | n/a | n/a | n/a | 3K | 11K | 62K | 103K | 167K | 180K | 190K | 61K | n/a | n/a | n/a |
Receivables | 1.13M | 1.18M | 2.41M | 1.61M | 1.77M | 2.14M | 1.78M | 2.17M | 2.61M | 2.66M | 1.35M | 1.83M | 1.97M | 1.31M | 899K | 1.67M | 1.3M | 1.26M |
Inventory | n/a | n/a | n/a | n/a | -6.23M | n/a | n/a | -5.26M | -2.61M | -3.46M | -2.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.91M | 2.92M | 2.28M | 3.38M | 4.47M | 4.49M | 3.65M | 5.26M | 3.7M | 3.46M | 2.87M | 4.58M | 5.62M | 5.91M | 4.45M | 3.47M | 3.79M | n/a |
Total Current Assets | 103.12M | 116.81M | 127.32M | 132.78M | 148.22M | 135.87M | 132.03M | 141.61M | 158.8M | 152.85M | 151.14M | 141.14M | 157.79M | 172.7M | 160.66M | 126.54M | 83.47M | 137.34M |
Property-Plant & Equipment | 148K | 168K | 4.36M | 4.7M | 5.3M | 5.74M | 6.09M | 6.54M | 6.96M | 6.52M | 6.81M | 7.06M | 7.42M | 7.67M | 8.07M | 8.53M | 9M | 8.9M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 148K | 202K | 4.39M | 7.66M | 11.82M | 14.42M | 12.37M | 17.03M | 18.02M | 38.37M | 44.28M | 62.66M | 58.05M | 64.18M | 43.82M | 39.06M | 51.91M | 8.9M |
Total Assets | 103.27M | 117.01M | 131.71M | 140.44M | 160.04M | 150.29M | 144.4M | 158.64M | 176.82M | 191.22M | 195.42M | 203.8M | 215.84M | 236.88M | 204.49M | 165.6M | 135.38M | 146.24M |
Account Payables | 1.32M | n/a | 2.32M | 2.31M | 2.65M | 3.74M | 3.22M | 2.26M | 1.04M | 2.46M | 3.52M | 872K | n/a | 1.19M | 3.17M | 1.04M | 2.06M | 355K |
Deferred Revenue | n/a | 6.76M | 7.57M | 10.91M | 11.03M | 11.55M | 11.79M | 12.11M | 15.33M | 15.05M | 16.46M | 14.88M | 16.97M | 23.25M | 7.64M | 8.65M | 6.29M | 5.71M |
Short-Term Debt | 514K | 563K | n/a | n/a | 453K | 502K | 425K | 412K | 397K | 446K | 372K | 360K | 377K | 439K | 383K | 386K | 357K | 432K |
Other Current Liabilities | 2.21M | 12.11M | n/a | 2.64M | 11.05M | 5.22M | 6.55M | 8.98M | 9.35M | 10.55M | 16.81M | 16.42M | 9.46M | 11.29M | -383K | -349K | -225K | -234K |
Total Current Liabilities | 5.02M | 19.43M | 15.62M | 18.92M | 22.59M | 20.3M | 22.49M | 22.32M | 24.53M | 25.15M | 32.86M | 27.51M | 29.82M | 32.41M | 11.22M | 10.11M | 8.84M | 6.69M |
Long-Term Debt | 3.91M | 626K | 4.83M | 5.32M | 5.86M | 6.4M | 6.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 10.78M | 17.8M | 10.22M | 8.34M | 7.99M | 7.78M | 7.6M | 15.48M | 15.96M | 17.19M | 17.9M | 18.24M | 19.94M | 20.94M | 21.59M | 22.99M | 23.23M | 22.92M |
Total Long-Term Liabilities | 15.27M | 18.42M | 18.72M | 14.63M | 14.99M | 15.36M | 15.9M | 16.98M | 17.6M | 22.16M | 25.71M | 30.78M | 32.87M | 38.62M | 23.82M | 25.34M | 25.71M | 25.4M |
Total Liabilities | 20.29M | 37.85M | 34.34M | 33.55M | 37.59M | 35.65M | 38.38M | 39.3M | 42.13M | 47.31M | 58.57M | 58.28M | 62.69M | 71.03M | 35.05M | 35.46M | 34.55M | 32.09M |
Total Debt | 5M | 1.19M | 1.29M | 1.45M | 7.46M | 8.08M | 8.72M | 1.91M | 2.04M | 2.12M | 2.19M | 2.31M | 2.46M | 2.54M | 2.61M | 2.74M | 2.83M | 2.91M |
Common Stock | 1.42B | n/a | 1.41B | 1.41B | 1.4B | 1.38B | 1.35B | 1.35B | 1.34B | 1.34B | 1.32B | 1.31B | 1.3B | 1.3B | 1.29B | 1.07B | 1.02B | 1.01B |
Retained Earnings | -1.37B | n/a | -1.35B | -1.33B | -1.31B | -1.29B | -1.28B | -1.26B | -1.24B | -1.22B | -1.2B | -1.18B | -1.16B | -1.15B | -1.13B | -1.11B | -1.09B | -1.07B |
Comprehensive Income | -48.19M | -48.17M | -48.13M | -48.09M | -48.31M | -48.37M | -48.42M | -48.88M | -49.47M | -49.63M | -50.49M | -51M | -50.1M | -49.41M | -48.34M | -48.19M | -48.2M | -48.17M |
Shareholders Equity | 82.98M | 79.16M | 97.37M | 106.89M | 122.45M | 114.64M | 106.02M | 119.34M | 134.69M | 143.91M | 136.85M | 145.52M | 153.14M | 165.84M | 169.44M | 130.14M | 100.83M | 114.15M |
Total Investments | 60.68M | 75.63M | 86.29M | 98.91M | 85.72M | 94.82M | 106M | 127.14M | 136.34M | 137.94M | 153.5M | 166.15M | 153.33M | 140.47M | 81.72M | 74.05M | 90.33M | 52.54M |